Treatment of ST-Segment Elevation Myocardial Infarction During COVID-19 Pandemic

The number of cases of the coronavirus-induced disease-2019 (COVID-19) continues to increase exponentially worldwide. In this crisis situation, the management of ST-segment elevation myocardial infarction (STEMI) is challenging. In this review, we outline the risks and benefits of primary PCI vs. th...

Descripción completa

Detalles Bibliográficos
Autores principales: Yerasi, Charan, Case, Brian C., Forrestal, Brian J., Chezar-Azerrad, Chava, Hashim, Hayder, Ben-Dor, Itsik, Satler, Lowell F., Mintz, Gary S., Waksman, Ron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241397/
https://www.ncbi.nlm.nih.gov/pubmed/32471712
http://dx.doi.org/10.1016/j.carrev.2020.05.027
_version_ 1783537063770980352
author Yerasi, Charan
Case, Brian C.
Forrestal, Brian J.
Chezar-Azerrad, Chava
Hashim, Hayder
Ben-Dor, Itsik
Satler, Lowell F.
Mintz, Gary S.
Waksman, Ron
author_facet Yerasi, Charan
Case, Brian C.
Forrestal, Brian J.
Chezar-Azerrad, Chava
Hashim, Hayder
Ben-Dor, Itsik
Satler, Lowell F.
Mintz, Gary S.
Waksman, Ron
author_sort Yerasi, Charan
collection PubMed
description The number of cases of the coronavirus-induced disease-2019 (COVID-19) continues to increase exponentially worldwide. In this crisis situation, the management of ST-segment elevation myocardial infarction (STEMI) is challenging. In this review, we outline the risks and benefits of primary PCI vs. thrombolysis for STEMI. While thrombolysis may seem like a good choice, many patients have a contraindication and could end up using more resources. Also, with a high probability of the angiogram showing non-obstructed coronary arteries during acute infections, primary PCI should be the preferred strategy.
format Online
Article
Text
id pubmed-7241397
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-72413972020-05-21 Treatment of ST-Segment Elevation Myocardial Infarction During COVID-19 Pandemic Yerasi, Charan Case, Brian C. Forrestal, Brian J. Chezar-Azerrad, Chava Hashim, Hayder Ben-Dor, Itsik Satler, Lowell F. Mintz, Gary S. Waksman, Ron Cardiovasc Revasc Med Reviews The number of cases of the coronavirus-induced disease-2019 (COVID-19) continues to increase exponentially worldwide. In this crisis situation, the management of ST-segment elevation myocardial infarction (STEMI) is challenging. In this review, we outline the risks and benefits of primary PCI vs. thrombolysis for STEMI. While thrombolysis may seem like a good choice, many patients have a contraindication and could end up using more resources. Also, with a high probability of the angiogram showing non-obstructed coronary arteries during acute infections, primary PCI should be the preferred strategy. Elsevier Inc. 2020-08 2020-05-21 /pmc/articles/PMC7241397/ /pubmed/32471712 http://dx.doi.org/10.1016/j.carrev.2020.05.027 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Reviews
Yerasi, Charan
Case, Brian C.
Forrestal, Brian J.
Chezar-Azerrad, Chava
Hashim, Hayder
Ben-Dor, Itsik
Satler, Lowell F.
Mintz, Gary S.
Waksman, Ron
Treatment of ST-Segment Elevation Myocardial Infarction During COVID-19 Pandemic
title Treatment of ST-Segment Elevation Myocardial Infarction During COVID-19 Pandemic
title_full Treatment of ST-Segment Elevation Myocardial Infarction During COVID-19 Pandemic
title_fullStr Treatment of ST-Segment Elevation Myocardial Infarction During COVID-19 Pandemic
title_full_unstemmed Treatment of ST-Segment Elevation Myocardial Infarction During COVID-19 Pandemic
title_short Treatment of ST-Segment Elevation Myocardial Infarction During COVID-19 Pandemic
title_sort treatment of st-segment elevation myocardial infarction during covid-19 pandemic
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241397/
https://www.ncbi.nlm.nih.gov/pubmed/32471712
http://dx.doi.org/10.1016/j.carrev.2020.05.027
work_keys_str_mv AT yerasicharan treatmentofstsegmentelevationmyocardialinfarctionduringcovid19pandemic
AT casebrianc treatmentofstsegmentelevationmyocardialinfarctionduringcovid19pandemic
AT forrestalbrianj treatmentofstsegmentelevationmyocardialinfarctionduringcovid19pandemic
AT chezarazerradchava treatmentofstsegmentelevationmyocardialinfarctionduringcovid19pandemic
AT hashimhayder treatmentofstsegmentelevationmyocardialinfarctionduringcovid19pandemic
AT bendoritsik treatmentofstsegmentelevationmyocardialinfarctionduringcovid19pandemic
AT satlerlowellf treatmentofstsegmentelevationmyocardialinfarctionduringcovid19pandemic
AT mintzgarys treatmentofstsegmentelevationmyocardialinfarctionduringcovid19pandemic
AT waksmanron treatmentofstsegmentelevationmyocardialinfarctionduringcovid19pandemic

Ejemplares similares